Whether you’re into HIIT, barre, or yoga, it’s likely that when you work out you do it with a goal in mind. You might be training to get stronger, to lose a little bit of weight, or help improve...

Type I diabetes mellitus (T1D) is an autoimmune disorder leading to permanent loss of insulin-producing beta-cells in the pancreas. In a new study, researchers from the University of Tokyo developed a...

As one of the original American Idol judges, Randy Jackson was an iconic presence on the show for a whopping 12 seasons. But he was also struggling with his health during that part of his life, and fans...

Researchers from the Barbara Davis Center for Childhood Diabetes at the University of Colorado Anschutz Medical Campus have found that immune responses to insulin could help identify individuals most...

For decades, physicians have known that about half of all patients with heart failure appear to have hearts that contract normally—a syndrome now known as heart failure with a preserved ejection fraction...

A team of scientists has shown that a key type of immune cell “self-renews” in humans. It is an unexpected discovery, as it was previously thought this specific type of “senescent”...

Researchers at the University of Utah School of Medicine have identified a new therapeutic target to treat patients with type 1 diabetes. The study, which will be published December 9 in the Journal of...

Immunotherapy for cancer has made great advances and many patients can now receive effective treatments that were not available 10 years ago. However, there are certain types of cancer that do not respond...

More than 20 million people in the U.S. suffer neuropathic pain. At least 25% of those cases are classified as unexplained and considered cryptogenic sensory polyneuropathy (CSPN). There is no information...

Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy. Patients given...